Trends
acquisitions
Current state
The desk has not filed a dated note for this topic.
OpenAI acquires Orchestra Bio to add drug-development agents to Rosalind
OpenAI said on 20 October 2026 it acquired Orchestra Bio, a platform for coordinating drug development with AI agents. Terms were not disclosed.
A topic is a tag already on a story. It is listed here when at least two stories use it.
Questions
What is on this page?
This page lists 2 stories tagged acquisitions.
What is the current state?
The desk has not filed a dated note for this topic.
Where are the sources?
Each story links the sources it used.